Cargando…
Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.
Ewing tumours (ET), including Ewing's sarcoma and peripheral primitive neuroectodermal tumour, are well characterised at the molecular level by a unique chromosomal rearrangement which fuses the EWS gene to one of two closely related ETS proto-oncogenes, FLI-1 or ERG. Expression of the resultin...
Autores principales: | Zoubek, A., Pfleiderer, C., Salzer-Kuntschik, M., Amann, G., Windhager, R., Fink, F. M., Koscielniak, E., Delattre, O., Strehl, S., Ambros, P. F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033557/ https://www.ncbi.nlm.nih.gov/pubmed/7524604 |
Ejemplares similares
-
Chimaeric antigen receptor T-cell therapy for tumour immunotherapy
por: Sha, Huan-huan, et al.
Publicado: (2017) -
Mechanism and relevance of EWS/FLI-mediated transcriptional repression in Ewing sarcoma
por: Sankar, Savita, et al.
Publicado: (2012) -
Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma
por: Hensel, Tim, et al.
Publicado: (2015) -
Systems biology of Ewing sarcoma: a network model of EWS-FLI1 effect on proliferation and apoptosis
por: Stoll, Gautier, et al.
Publicado: (2013) -
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
por: Lu, Diana Y., et al.
Publicado: (2023)